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Background: Male infertility has largely idiopathic, multifactorial origin. Oxidative stress is a major factor that affects
spermatogenesis, in particular in aging. Cerium dioxide nanoparticles (CNPs) due to their antioxidative properties
are promising to impact on the development of male infertility. The aims of this study were to investigate the
effects of CNPs on fertility parameters in 24-month male rats and to overview relevant literature in the field of
personalized treatments, predictive diagnosis, and preventive measures for male health and fertility.
Methods: We included 30 24-month-old male rats. After a week of adaptation to the standard diet, the rats were
randomly divided into three groups with ten rats in each. Group 1 (controls) received only a standard diet. The rats
of group 2 and 3 in adjunct to the standard diet during 10 days received intragastrically 10 % sodium citrate and
citrate-coated CNPs in dose 1 mg/kg, respectively. We assessed sex hormones, epididymal sperm parameters and
spermatogenesis, ultrasound, and morphological data of rat reproductive organs.
Results: After a 10-day administration of CNPs, we revealed significant decrease of lipid peroxidation product
levels in serum and increase of catalase and SOD activity, associated with increase of sperm count (p < 0.001) and
improvement in quantitative sperm parameters (motility, viability, and percentage of spermatozoa). We found no
significant changes between sperm quantitative parameters in citrate-treated rats and controls and observed
age-related decrease of activated Leydig cell number and focal atrophy of the seminiferous tubules. In CNP
group, we observed regeneration of seminiferous tubules, increase number and activation of Leydig cells, and
2.5-fold significant increase of serum testosterone. Ultrasound data showed the slight increase of linear measurement
and volume of rat testes in CNP group. Review highlights the benefits for predictive diagnosis, preventive measures,
and personalized approaches to manage male infertility in the general concept of male health also related to aging.
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Conclusion: Citrate-coated 2–5-nm CNPs lead to increase in sex hormones levels, sperm count, and quality, as
well as the activation of spermatogenesis in 24-month-old male rats. Nanoceria demonstrated the perspectives
to be an effective infertility treatment via reduction of oxidative stress in male reproductive organs, in particular
in aging.
Keywords: Predictive, preventive, and personalized medicine, Nanocrystalline cerium dioxide, Age-related male
infertility, Oxidative–antioxidative balance, Infertility biomarkers, Seminal plasma, Ultrasound, Translation, Men healthOverview
Predictive, preventive, and personalized medicine for
male infertility. Aspects of oxidative stress—challenge for
nanomedicine
The tasks of predictive, preventive, and personalized
medicine (PPPM) is to develop well-balanced family life
through all life spans in aging society and promote sus-
tainable reproduction health and healthy new gener-
ation. The issue of the health of elderly in aging society
and fertility of males is the crucially important task for
medicine of the future which is focused in the separate
paragraphs of granting research programs.
Cerium dioxide (CeO2) nanoparticles (CNPs) have shown
promise as a therapeutic application due to their antioxi-
dant auto-regenerative ability and low toxicity [1, 2]. The
electronic structure of CNPs at the nanoscale leads to their
antioxidant activity. Both large surface-area-to-volume ratio
with the reduction in particle size [3, 4] and ability to re-
versibly switch between Ce3+ and Ce4+ present on the sur-
face [5, 6] result in the formation of oxygen defects in the
crystal lattice that act as “reactive sites” or “hot spots” for
free radical scavenging [7]. A schematic model explaining
CNP surface regeneration and its activity is shown in Fig. 1.
The combination of auto-catalytic and regenerative proper-
ties makes CNPs desirable therapeutic agents [8, 9].Fig. 1 Schematic model of catalase-like (A1, A2) and superoxide dismutase
lattice [2] (right)The recent studies confirmed that CNPs exhibit super-
oxide dismutase (SOD) [10, 11] and catalase mimetic ac-
tivity [12] and also have the ability to scavenge hydroxyl
(·OH) [13] or nitric oxide (·NO) radicals [14]. Several re-
ports demonstrated that CNPs with size less than 10
nm, regardless of the dose, did not induce overt toxicity
or immune response and are well tolerated by the ex-
perimental animals [15, 16].
Reactive oxygen species (ROS) can exhibit a dual
effect on the male reproductive system. In a healthy
organism, small amounts of ROS are produced by
spermatozoa and they play an important role as key sig-
nal molecules which are involved in capacitation and
the acrosome reaction [17, 18]. The balance between
their production and inactivation by various scavengers
is strongly controlled due to physiological conditions
[19]. Violation of this balance occurs with aging and
under various reproductive disorders which lead to
enhanced ROS formation or impaired mechanisms of
antioxidant production results in oxidative stress [20].
In both human and animal studies, the role of oxidative
stress within sperm was emphasized, resulting in DNA
damage [21, 22], reduced sperm parameters [23, 24]
and gene expression [25, 26], and defective membrane
integrity [19].-like (B) activities of CNP (left) and corresponding changes in ceria
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in dose 1 mg/kg had a stimulating effect on spermato-
genesis in 18-month male rats. CNPs at a dose 100 mg/kg
had no significant effect on the assessed indices of the
morpho-functional condition of reproductive system [27].
Men health in the point of view of reproduction, per-
sonal health, and life quality is still not sufficiently stud-
ied and implemented in predictive assessment and
widespread screening programs.
Therefore, the aims of this study are to investigate the
effect of CNPs on qualitative and quantitative sperm pa-
rameters, spermatogenesis, sex hormone levels, and pro/
antioxidant condition in 24-month male rats, to over-
view relevant literature in the field of personalized treat-
ments, predictive diagnosis, and preventive measures for
male fertility, and to suggest the translating and imple-
mentation of obtained data in the concept of predictive,
preventive, and personalized medicine.
Methods
Synthesis of citrate-coated CNPs
Colloid 0.1 M solutions of CNPs stabilized by 0.1 М am-
monium citrate were synthesized as follows [28]: 3.73 g
of cerium (III) chloride heptahydrate and 2.0 g of citric
acid were dissolved in 20 mL of distilled water. Under
continuous stirring, this solution was added rapidly to
an aqueous ammonia solution prepared by mixing 10 g
of concentrated ammonia solution (Sigma, USA) and
100 mL of distilled water. The resulting mixture was
stirred for 5 h, with further boiling aiming at producing
100 mL of 0.1 M ceria sol. Finally, the sol was purified
by precipitation-redispersion with isopropyl alcohol and
boiled.
Optical absorption spectra were recorded on an
OceanOptics QE 65000 spectrometer using a one beam
scheme. The radiation sources were a DH 2000 deuterium–
halogen lamp and an HPX 2000 xenon lamp. According
to UV-vis spectroscopy data, the bandgap for CNPs isFig. 2 High-resolution electron micrograph (HRTEM) of ceria nanoparticles
distribution of the effective potential of the citrate anion adsorbed on the3.5 eV. Upon long-term storage, the bandgap of CNPs
stayed unchanged, thus indicating that the particle size
in ceria sols is constant.
The size of CNPs was determined by transmission
electron microscopy (TEM) on a Leo 912 AB Omega
electron microscope at 100 kV accelerating voltage. Ac-
cording to TEM micrographs and electron diffraction
data (Fig. 2), the solution consists of weakly aggregated
CNPs of nearly isotropic shape 2–5 nm in size.
The hydrodynamic diameter by the dynamic light scat-
tering (DLS) method and zeta potential of citrate-coated
CNPs was measured on a Malvern Zetasizer Nano ZS
analyzer. Before the measurements, the sol was diluted
with distilled water. DLS data indicate that mean hydro-
dynamic diameter of CNPs is 4.9 nm. This is consistent
with the TEM data and is evident that the presence of a
monomolecular (or sub monomolecular) layer of citrate
ions has no noticeable effect on the particle size. Zeta
potential of CNPs is negative (−20 mV).
Powder X-ray diffraction (XRD) analysis of ceria nano-
powders prepared by sol centrifuging was carried out on a
Rigaku D/MAX 2500 diffractometer (CuKα radiation,
instrumental broadening 0.10 ± 0.01°2θ). The goniometer
rotation speed was 2°2θ/min. Crystallite size (D) of nano-
crystalline ceria was calculated using Scherrer formula where
the coefficient of anisotropy was set to 1. Line profiles for
(111) and (200) reflections were fitted to pseudo-Voigt func-
tions. XRD has shown that the particles separated from the
sol by centrifuging are single-phased and correspond to
cubic CeO2. Analysis of diffraction peaks broadening indi-
cates that the synthesis method proposed allowed us to ob-
tain ceria samples with crystallite size about 3 nm.
Study design
After 1 week of adaptation to a standard diet, 24-month
rats were randomly divided to one of the three groups
with ten rats in each group. Group 1 (controls) received
only a standard diet. Rats of group 2 and 3 in adjunct to(4–5 nm) stabilized by citrate (a). The model of lattice and 3D spatial
cluster Ce7O12 (b) [1]
Table 1 Johnsen score for spermatogenesis assessment
Score Histological criteria
10 Full spermatogenesis
9 Slightly impaired spermatogenesis, many late spermatids,
disorganized epithelium
8 Less than five spermatozoa per tubule, few late spermatids
7 No spermatozoa, no late spermatids, many early spermatids
6 No spermatozoa, no late spermatids, few early spermatids
5 No spermatozoa or spermatids, many spermatocytes
4 No spermatozoa or spermatids, few spermatocytes
3 Spermatogonia only
2 No germinal cells, Sertoli cells only
1 No seminiferous epithelium
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10 days with 10 % sodium citrate or citrate-coated CNPs
in dose 1 mg/kg, respectively.
After 35 days from starting the experiment (about one
duration of spermatogenesis), all rats from three experi-
mental groups (n = 30) were killed by cervical dislocation
under urethane anesthesia. Immediately after dissection,
testis, epididymis, ventral prostate, and seminal vesicle
(without the coagulating gland) were removed and
weighted (absolute and relative to body weight). Relative
organ weight was expressed as organ weight (mg)/body
weight (g).
Sample collection and blood biochemistry analysis
Blood was drawn from the apex of the cardiac ventricle,
and few blood drops were collected into a microcentri-
fuge tube containing a mixture of NaF and EDTA in a
2:1 (w/w) ratio. The blood sample was collected into a
sterile tube and centrifuged at 3,500 rpm (2260 g) for 15
min. After centrifugation, serum supernatant for further
analysis was aliquoted into microcentrifuge tubes and
stored at −80 °C. ELISA was used for determination of
serum testosterone and luteinizing hormone (LH) level
by commercial kits «BioVendor» (Czech Republic).
Sperm parameter assessment
Sperms acquired from the tail of the left epididymis were
released to 2 ml of saline (0.9 % NaCl). After 15 min of
incubation, one drop of sperm suspension were removed
to Goryaev counting chamber, covered by a 22 × 22-mm
coverslip to estimate sperm count, viability, motility, and
morphology according to WHO protocols [29]. Under a
light microscope, Olympus BX51 (Olympus Optical Co.
Ltd., Tokyo, Japan) at ×400 magnification, the total
sperm counts were calculated and the value was
expressed as ×106/mL.
At least 200 sperms for each specimen in the mini-
mum of five microscopic fields were assessed to evaluate
sperm motility. Sperm motility was expressed in per-
centages and categorized as follows:
 Grade A—registration of rapid motility (movement
in straight lines with a speed of not less than 25 μm/s
or cover the distance equal to its length for 2 s).
 Grade B—slow motility (movement in straight lines
with a speed less than 25 μm/s). Grade A + B
according to the WHO protocol (2010) classified as
“sperm with progressive motility”.
 Grade C—nonprogressive motility (spermatozoa do
not move forward despite the movement of their tails).
 Grade D—immotile sperm (fail to move at all).
For evaluation of sperm viability, a drop of sperm suspen-
sion was mixed with an equal volume of 0.05 % eosin Y.The mixture was incubated at room temperature for 2 min
and analyzed under a light microscope, at ×400 magnifica-
tion. Dead sperm cells were stained red while live sperm
cells were unstained. A total of 100 spermatozoa per sample
were counted and part of viable sperm were expressed as
the percentages.
The sperm was stained with hematoxylin for morpho-
logical anomaly assessment. A total of 100 spermatozoa
from different fields were classified in next general cat-
egories: such as normal, abnormalities of the sperm head
(abnormal shape, size, double or triangular head, ab-
sence or reduced acrosome), or abnormalities of the fla-
gellum (bending, lack or plural number of flagella,
abnormal size). The sum of abnormal spermatozoa was
expressed as the percentage.Histological analysis of testes
For histological studies, the transversal cuts of right tes-
tes were performed from the central part and fixed in
10 % neutral formalin solution. The pieces were dehy-
drated in a graded ethanol series of 70–100 % and proc-
essed for embedding in paraffin. Then, 3–5-m sections
were achieved from paraffin blocks and subsequently
stained with hematoxylin and eosin (H&E) and examined
by light microscopy on an Olympus BX51 (Olympus
Optical Co. Ltd., Tokyo, Japan). Johnsen’s score was used
for spermatogenesis assessment [30]. Briefly, more than
100 cross sections of the seminiferous tubules from each
animal were scored as represented in Table 1, and the
mean value was calculated.Measurements of lipid peroxidation
The content of primary lipid peroxidation (LPO) prod-
ucts (diene conjugates) in serum was measured spectro-
photometrically [31]. The content of thiobarbituric acid
reactive substances (TBA-reactive substances) was stud-
ied by the reaction with thiobarbituric acid [32]. The
Kobyliak et al. The EPMA Journal  (2015) 6:12 Page 5 of 22concentration of Schiff bases, final lipid peroxidation
products, was measured fluorometrically [33].
Measurements of antioxidant enzyme activities
The antioxidant system state was estimated by the activ-
ities of SOD [34] and catalase [35] in serum.
Ultrasound of the rat testes
We performed ultrasonography (US) of testes in rats using
linear 5–12 MHz frequency probes of ultrasound scanner
Ultrasound Philips/ATL HDI 3500 (Netherlands) before
and 30 days after the intervention. We obtained transver-
sal and longitudinal measurements and calculated volume.
We used the most common formula to calculate a testicu-
lar volume for an ellipsoid structure: length (L) × width
(W) × height (H) × 0.52.
Statistical analysis
Statistical analysis performed by using the SPSS-20 soft-
ware. All data in this study were expressed as means ±
standard error (M ± SE) or %. Data distribution was ana-
lyzed using the Kolmogorov–Smirnov normality test.
Continuous variables with parametric distribution were
then analyzed using analysis of variance (ANOVA), and
if the results were significant, a post hoc Tukey test was
performed. For data with nonparametric distribution,
Kruskall–Wallis test was used. For comparisons of cat-
egorical variables, we conducted a χ2 test. The difference
between groups was defined to be statistically significant
when a p value was less than 0.05.
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health
and the general ethical principles of animal experiments
approved by the First National Congress on Bioethics
Ukraine (September 2001). The protocol was approved
by the Committee on the Ethics of Animal Experiments
of the Taras Shevchenko National University of Kyiv.
The rats were kept in collective cages in controlled con-
ditions of temperature (22 ± 3 °C), light (12 h light–dark
cycle), and the relative humidity (60 ± 5 %). The animals
were fed laboratory chow (PurinaW) and tap water ad
libitum.
Results
Body and reproductive organ weights
The total body weight of rats after a 10-day administra-
tion of CNPs or citrate did not differ from that of the
control animals. The external examination of the male
reproductive organs did not find differences between the
control and both treated groups. We showed compar-
able similar absolute and relative reproductive organweight in experimental and control groups, respectively.
The only difference from those of the control group is a
statistical tendency to increase the seminal vesicles
weight in both treated groups (p = 0.084). The data are
summarized in Table 2. Motor activity, appearance, and
food and water consumption were similar in all groups.
All these data indicate the absence of a toxic effect of
CNPs and citrate on aging male rats in conditions of the
10-day administration.
Serum sex hormone level
Evaluation of the blood serum testosterone (Fig. 3a)
showed that in the control group, the individual value
ranged from 1.54 to 7.21 nmol/L (with mean value of
3.81 ± 0.56 nmol/L), which corresponded to an age-
dependent decrease of hormone in male rats. Adminis-
tration of CNPs was accompanied with 2.5- and 2-fold
significant increase of serum testosterone and LH level,
respectively, as compared with the control and citrate-
treated rats (Fig. 3). Citrate administration did not lead
to significant changes of testosterone (p = 0.985) or LH
(p = 0.698) values when compared with the control
group.
Epididymal sperm parameters
The qualitative and quantitative sperm parameters for
all groups are summarized in Table 3. Administration of
CNPs at dose 1 mg/kg for 10 days resulted in significant
increase of sperm count by 18.7 % (p < 0.001) and
16.0 % (p < 0.001) as compared with the control and
citrate-treated groups, respectively.
Our results indicated a significant improvement of
sperm progressive motility (grade A + B) after CNP treat-
ment as compared with other groups. These changes were
associated with significant increase of rapid motility sperm
count (grade A) by 29.5 % (p = 0.002) parallel with re-
markable decrease of spermatozoa with nonprogressive
motility (grade C) by 29.6 % (p = 0.001) and immotile
spermatozoa (grade D) by 25.2 % (p = 0.022) as compared
with the control. Similar changes were revealed when
comparing both treated groups. But significant changes
were not demonstrated between sperm motility parame-
ters in control and citrate-treated rats (Table 3).
Sperm viability was significantly increased by 7.3 % in
rats after treatment with CNPs when compared with the
control group (p = 0.016). No significant changes were
observed between both treated groups (p = 0.136).
In addition, the percentage of normal sperm morph-
ology was significantly increased in rats that received
CNPs as compared with the control group (p = 0.013)
and no difference was found for citrate-treated group
(p = 0.054). The percentages of an abnormal flagellum
(coiled tail, wrong angle connection to the head) were
7.75 ± 0.77 in rats of the CNP group and were more
Table 2 Total body weight, absolute and relative reproductive organ weights of male rats
Parameters Control (n = 10) Citrate (n = 10) CNPs (n = 10) p
Absolute weight
Total body weight, g 396.2 ± 6.48 405.6 ± 9.26 403.5 ± 7.45 0.676
Testis, mg 2991.3 ± 98.91 2997.5 ± 107.72 3047.5 ± 70.02 0.897
Epididymis, mg 985.7 ± 28.5 970.4 ± 21.78 987.0 ± 37.74 0.910
Seminal vesicle, mg 727.1 ± 9.74 756.4 ± 10.35 754.8 ± 9.85 0.084
Ventral prostate, mg 498.02 ± 8.04 497.87 ± 7.75 492.61 ± 8.04 0.832
Relative weight
Testis, mg/100 g 7.53 ± 0.18 7.37 ± 0.16 7.56 ± 0.18 0.730
Epididymis, mg/100 g 2.48 ± 0.05 2.39 ± 0.04 2.44 ± 0.07 0.551
Seminal vesicle, mg/100 g 1.83 ± 0.01 1.86 ± 0.03 1.86 ± 0.03 0.614
Ventral prostate, mg/100 g 1.25 ± 0.01 1.21 ± 0.01 1.22 ± 0.02 0.252
Values expressed as mean ± SEM. One-way ANOVA test was performed
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percentage of spermatozoa with abnormalities of head
and flagellum significantly decreased only after treat-
ment with CNPs when compared with intact rats.
Histological assessment of the testes
Histological analysis has shown that the morphological
structure of the testes of aging males in the control group
corresponded to the overall picture of age-related changes.
We indicated irregular partially regressed (contained fewer
spermatogenic cells) or fully regressed (contained no sper-
matogenic cells) seminiferous tubules (Fig. 4a, b). The
focal atrophy in the seminiferous tubules was associated
with the loss of spermatogenic cells as a result in part or
completely from a decreased ability of Sertoli cells to sup-
port germ cell survival and differentiation. Also in the
control group, we found the number of activated Leydig
cells (mean in volume and poor vacuolated cytoplasm,
slightly hyperchromic, oval-shaped nuclei) decreasing.Fig. 3 Testosterone and LH level in rats of different experimental groups. V
Tukey test was performed. a, b Mean values with the same letter do not dAfter the 10-day treatment with CNPs, we observed
the signs of regeneration in seminiferous tubules which
were related to increased number and focal proliferation
of spermatogenic cells (Fig. 4e, f ). Also, the number of
activated Leydig cells increased. Their activation indi-
cates the presence of larger in volume and size normo-
chromic nuclei with clear nucleoli as compared with the
control. Their cytoplasm was also greater with increased
number of vacuoles on the cell periphery. Activation of
Leydig cells may be responsible for increasing testoster-
one levels in the blood plasma, which was set previously.
Visual signs of a stimulation of spermatogenesis in rats
that received CNPs were confirmed by Johnson score as-
sessment. As it is shown in Fig. 5, administration of
CNPs resulted in the increase of mean values by 2 and 1
point of Johnson score as compared with the control
and citrate-treated rats.
Finally, we can perceive that administration of CNPs,
but not citrate, slightly reduces the signs of age-relatedalues expressed as mean ± SEM. One-way ANOVA test followed by
iffer statistically; values <0.05 were considered significant
Table 3 Epididymal sperm parameters in different experimental groups
Sperm parameters Control (n = 10) Citrate (n = 10) CNPs (n = 10)
Concentration (106/mL) 37.11 ± 1.32а 37.97 ± 1.04а 44.05 ± 1.49b
Rapid motility, % (grade A) 29.21 ± 1.3а 30.67 ± 0.72а 37.96 ± 1.5b
Slow motility, % (grade B) 25.56 ± 2.03а 25.57 ± 1.63а 29.31 ± 1.08а
Progressive motility, % (grade A + B) 54.77 ± 1.81а 56.24 ± 1.38а 67.27 ± 1.78b
Non-progressive motility, % (grade C) 25.02 ± 1.49а 23.87 ± 0.84а 17.61 ± 1.24b
Immotile sperm, % (grade D) 20.21 ± 1.58а 19.86 ± 1.11а 15.11 ± 1.02b
Viability, % 83.36 ± 1.64а 85.37 ± 1.33аb 89.3 ± 1.18b
Normal morphology, % 83.25 ± 1.28а 84.4 ± 1.22аb 88.85 ± 1.35b
Abnormalities of the sperm head, % 5.95 ± 0.57а 5.15 ± 0.57аb 3.4 ± 0.64b
Abnormalities of the flagellum, % 10.8 ± 0.87а 10.55 ± 0.9аb 7.75 ± 0.77b
Values expressed as mean ± SEM. One-way ANOVA test followed by Tukey test was performed. Mean values with the same letter do not differ statistically; p values
<0.05 were considered significant
Fig. 4 Light microscopy of cross sections of H&E stained testis. a, b Control group; c, d citrate-treated group; e, f CNP-treated group. Regular
seminiferous tubules (a) with atrophy of spermatogenic epithelium. Irregular seminiferous tubules where spermatogenic layer is represented by
focal and low amounts of cells which does not provide normal maturation of sperm; in the lumen, small amount of spermatozoa (b–d). There is
a partial recovery of spermatogenic layer in the seminiferous tubules compared with the control group—observed a higher amounts of cells
which are placed in several rows; the presence of spermatozoa in the lumen (e, f). Final magnification: ×400
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Fig. 5 Assessment of spermatogenesis using Johnson score. Values
expressed as mean ± SEM. One-way ANOVA test followed by Tukey
test was performed. a, b Mean values with the same letter do not
differ statistically; p values <0.05 were considered significant
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spermatogenesis.
Products of lipid peroxidation and antioxidant enzyme
activities
The level of LPO products is one of the biochemical
markers of oxidative–antioxidative balance. We deter-
mined the content of primary LPO products—conju-
gated dienes, intermediate, TBA-reactive substances, and
the end LPO products—Shiff bases.
We revealed that after CNP administration, the content
of LPO products in serum significantly decreased: conju-
gated dienes—2.1 times, TBA-reactive substances—1.5
times and Schiff bases—2.9 times as compared to the con-
trol or citrate-treated groups (Table 4). The activity of
SOD and catalase was significantly increased by 1.5-fold
in rats which received CNPs when compared with other
groups (Table 4).
Ultrasound assessment of testes
We obtained a slight increase of linear measurements of
testes in the CNP group as follows: 11 ± 1.1 mm × 11 ±
1.3 mm × 15 ± 1.5 mm on baseline before CNP intro-
duction up to 12 ± 1.2 mm × 12 ± 1.3 mm × 17 ± 1.6Table 4 Products of lipid peroxidation and antioxidant enzymes act
Parameters Control (n
Conjugated dienes, nmol × mg protein−1 80.79 ± 6.0
TBA-reactive substances, nmol × mg protein−1 41.22 ± 3.0
Schiff bases, units × mg protein−1 5.61 ± 0.51
SOD, units × min−1 × mg protein−1 0.11 ± 0.01
Catalase, nmol × min−1 × mg protein−1 0.44 ± 0.04
Values expressed as mean ± SEM. One-way analysis of variance (ANOVA) test follow
differ statistically; p values <0.05 were considered significantmm on the 30th day of experiment (p > 0.05). In con-
trols, linear measurements of testes were on the 30th
day of experiment 11 ± 1.1 mm × 10.8 ± 1.4 mm × 15 ±
1.5 mm, and in the citrate group, 11 ± 1.1 mm × 11 ±
1.2 mm × 13 ± 1.6 mm, respectively.
Volume changes were calculated as 0.943 ± 0.44 ml on
baseline vs 1.272 ± 0.5 ml (p > 0.05) in the CNP group,
and insignificant decrease to 0.817 ± 0.42 was calculated
for the citrate group (p > 0.1). Changes in the echo
structure of testes were not registered (Fig. 6).
Discussion
There are several factors which could influence the CNP
catalytic activity, as well as their antioxidant or pro-
oxidant biological response. Tissue environmental condi-
tions such as pH play an important role in the determin-
ation of CNP direct oxidant behavior [36, 37]. In a
neutral pH environment, CNPs act as antioxidant that is
cytoprotective agent [38]. Conversely, in pancreatic can-
cer cells (L3.6pl) with acidic pH, pretreatment with
CNPs revealed a twofold increase in ROS after 30 min
and up to 24 h of postradiation exposure. In normal
CNP-treated pancreatic cells, there was a 50 % decrease
in ROS [39]. In pH-dependent pro-oxidant effect condi-
tioned by inhibition of catalase activity [40] in cancer
cells, CNPs are only capable of catalyzing the conversion
of highly unstable superoxide to far more stable H2O2.
Without catalase mimetic ability to remove H2O2, CNPs
actually increased the toxicity of radiotherapy in cancer
cells due to an accumulation of ROS in the cell [39].
Synthesis methods and physiochemical properties
(size, shape, agglomeration status in liquid and coating)
of CNPs could also influence their biological response
and catalytic activity. Several nanocomposites of CNPs
used for coating biocompatible polymers (polyethylene
glycol, dextran, polyacrylic acid, citric and oleic acid)
were described [8]. Coating of nanoparticles with a sur-
factant or biocompatible polymers improves stability, in-
creases dispersion and blood circulation time, decreases
nonspecific interactions with cells and proteins, and re-
duced toxicity [8, 41]. In our study, we used near-
shaped, citrate-coated CNPs with particle size 2–5 nm.
Ammonium citrate in nanocomposites serves not onlyivities in different experimental groups
= 10) Citrate (n = 10) CNPs (n = 10)
2a 77.9 ± 4.3a 37.07 ± 3.27b
2a 37.94 ± 3.59a 27.06 ± 2.55b
a 5.26 ± 0.4a 1.82 ± 0.54b
a 0.11 ± 0.01a 0.16 ± 0.01b
a 0.45 ± 0.04a 0.63 ± 0.05b
ed by Tukey test was performed. Mean values with the same letter do not
Fig. 6 Ultrasound assessment of testes in rats. a View of ultrasound
technique to obtain transversal scans of testes in rat. b Transversal
US scans of testes (T) and linear measurements
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stability of CNPs in water and biologically relevant
media, but also plays an important role in the pharma-
cokinetics of CNPs in the cells and established that
ammonium citrate formed a multinuclear complex with
CNPs leading to the formation of monodisperse, uniform
in size (2–5 nm) particles. Additionally, citrate provides a
negative zeta potential of CNPs that are less toxic to nor-
mal mammalian cells. Finally, citrate as a compound in
Krebs cycle provides CNPs to the mitochondria where
under the pathologic conditions ROS forms leading to
oxidative stress. Therefore, the CNP antioxidant function
appears in the zone of maximum ROS concentration. In
our study for distinguishing biological response of both
nanocomposite components, we used sodium citrate as
active comparator to CNPs in the same dose and course.
Most prominent factors associated with age-related
decrease of spermatogenesis and steroidogenesis are dys-
regulation of the hypothalamus–pituitary axis, reduction
of Leydig cell count, which produced more than 60 % of
androgens, lower density of LH receptors in the cells,
and decrease in testosterone synthesis enzyme activity.Also, it has been shown that apoptosis increases with
age producing an accelerated germ cell loss as a result of
oxidative stress in the tissue [42].
ROS are defined as molecules with one or more un-
paired electrons in their outer orbital. Due to the pres-
ence of unpaired electrons, these molecules are very
unstable and tend to react with neighboring molecules,
depriving them of electrons and thus altering their struc-
ture and function. ROS can damage cells by starting
chemical chain reactions such as lipid peroxidation or
by oxidizing DNA or proteins [43].
ROS can exhibit a dual effect on the male reproductive
system. In a healthy organism, small amounts of ROS
are produced by spermatozoa and they play an import-
ant role as key signal molecules which are involved in
capacitation and acrosome reaction [17, 18]. The balance
between their production and inactivation by various
scavengers is strongly controlled due to physiological
conditions [19]. Violation of this balance occurs with
aging. ROS level is positively correlated with the propor-
tion of sperm with amorphous heads, damaged acro-
somes, midpiece defects, cytoplasmic droplets, and tail
defects [44]. Excessive ROS formation leads to peroxida-
tion of phospholipids in the spermatozoa mitochondria
and thus impairs their motility [45] or can damage the
sperm membrane and flagellum structure and disrupt
morphology [23]. Oxidative stress within a sperm results
in protein or DNA damage that leads to a reduction in
Leydig cells and synthesis of testosterone [46]. This oxi-
dative stress-induced sperm damage has been suggested
to be a significant contributing factor in 30–80 % of all
cases of male infertility [47].
CNPs due to self-regenerative ROS scavenging prop-
erty have been used in different areas of medicine where
pathologies are associated with excessive oxidative stress.
Therefore, we aimed in this study to investigate the ef-
fect of CNPs on qualitative and quantitative sperm pa-
rameters, spermatogenesis, sex hormone levels, and pro/
antioxidant state in 24-month male rats. We revealed
that after 10 days, administration of CNP level of LPO
in serum significantly decreased by 1.5–2.9 times, par-
allel with 1.5-fold increase of catalase and SOD activ-
ity. These changes of oxidative–antioxidative balance
were associated with increase of sperm count by
18.7 % (p < 0.001) and improvement in quantitative
sperm parameters such as motility, viability, and per-
centage of spermatozoa with normal morphology in
rats that received CNPs as compared with the control
group. We indicated an increase of rapid motility
sperm count (grade A) by reducing spermatozoa with
nonprogressive motility (grade C) and immotile sperm-
atozoa (grade D). Significant changes within sperm
quantitative parameters in control and citrate-treated
rats were not designated.
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the number of activated Leydig cells and focal atrophy of
the seminiferous tubules which are often adjacent to tu-
bules exhibiting normal spermatogenesis. These data are
in agreement with previously reported studies [48, 49].
After the 10-day treatment with CNPs, but not with
citrate, we observed signs of regeneration in the semin-
iferous tubules. Visual signs of spermatogenesis stimula-
tion were confirmed by 2-point increase of mean values
of Johnson score after CNP administration as compared
with the control rats.
Activation of Leydig cells may trigger a 2.5-fold signifi-
cant increase of serum testosterone. Citrate administra-
tion did not lead to significant changes of testosterone
(p = 0.985) or LH (p = 0.698) values when compared
with the control group.
The determination of organ weights is an important
parameter for assessing the risk of toxicity on the male
reproductive system [50]. In our experiment, we have
measured comparatively similar absolute and relative re-
productive organs weights data in all groups, and testes
sizes were visualized in vivo on ultrasound which indicates
the absence of a toxic effect of CNPs and citrate on aging
male rats in conditions of the 10-day administration.
Toxicity of cerium oxide nanoparticles
The toxicity of cerium oxide (CeO2) nanoparticles (NPs)
was reported as low [1–16]; however, in several issues (e.g.,
in regard to reproduction, potential environmental con-
tamination, etc.), it still remains largely unknown.
The internalization and subcellular localization of
nanoceria plays a key role in the nanoparticles’ cytotox-
icity profile, exhibiting significant toxicity when they
localize into the lysosomes of the cancer cells. In con-
trast, minimal toxicity is observed when they localize
into the cytoplasm or do not enter the cells. Taken to-
gether, these results indicate that the differential surface
charge-dependent localization of nanoceria in normal
and cancer cells plays a critical role in the nanoparticles’
toxicity profile [37]. In our study, we used coating of
nanoparticles with the surfactant or biocompatible poly-
mers that improve stability, increase dispersion and
blood circulation time, decrease nonspecific interactions
with cells and proteins, and reduce toxicity.
Tourinho et al. concluded in their study [51] that
CeO2 NPs have a low toxicity and do not affect a toxicity
of phenanthrene to isopods and springtails. The data of
the study by Lahive et al. suggest that CeO2 NPs do not
affect survival or reproduction in earthworm E. fetida
over the standard test period. However, there were histo-
logical changes that could indicate possible deleterious
effects over longer-term exposures [52].
CNPs can protect the gastrointestinal epithelium
against radiation-induced damage both by acting as freeradical scavengers and by increasing the production of
superoxide dismutase 2 (SOD2) before radiation insult
[53]. We recently reported effects of CeO2 nanoparticles
affecting gastrointestinal motility on rat model and
reviewed data supporting their perspectives to be applied
as effective laxatives [54].
A detailed investigation on the agglomeration of oxide
nanoparticles in wastewater streams revealed a high
stabilization of the particles against clearance [55]. The
current available data do not suggest an immediate risk
from acute exposures to nanoceria from use as a fuel
additive or mechanical/chemical polishing or planariza-
tion. However, the data gaps should be addressed before
a comprehensive ecological risk assessment can be per-
formed for ceria for chronic exposures or for other ex-
posure pathways [56, 57].
Translation to human men health within the concept of
PPPM
In recent decades, infertility has impacted an increasing
number of couples. The tasks of PPPM are to develop
well-balanced family life through all life spans in aging
society and promote sustainable reproduction health and
new healthy generation [58].
For effective translation to a human organism, we
should consider a number of factors. Human infertility
depends on many psychological, medical, and social as-
pects and is manifested by symptoms that are similar to
those on the rat model mostly in a laboratory scale. Life-
style, collateral diseases, psycho-emotional status, and re-
lated conditions should be assessed carefully in human
studies to suggest integrated programs facing the problem.
Social aspects
In 2006, approximately 10 % of couples in the United
States are defined as infertile based on the inability to
conceive after 12 months of unprotected intercourse
[59, 60]. In the United States since 1980, the birth rate
in women older than age 35 years increased by nearly
60 %, whereas the birth rate for women aged 20 to 34
years increased by only 10 %.
This trend, in addition to an age-related decline in fer-
tility, has led to an increased need for advanced repro-
ductive technology for couples.
The trend for parenthood at an older age has also been
seen in men. Since 1980, the fertility rate for men in
their 30s has increased by 21 % and for men aged ≥40
years, the rate has increased nearly 30 %. In contrast, the
fertility rate in men younger than age 30 years has de-
creased by 15 % [61].
In recent years, these tendencies were kept. Thus, ac-
cording to the report on data births in the United States
in 2013 [62], the fertility rate of men was 45.8 births per
1000 men aged 15–54, down 1 % from 2012. Similar to
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under age 30 (down 11 % for ages 15–19, 4 % for ages
20–24, and 2 % for ages 25–29); rose for men aged 35–
54 (up 1–2 % for age groups 35–39, 40–44, and 45–49,
and 4 % for ages 50–54); and were unchanged for men
aged 30–34 and 55 and over. Rates for men aged 15–19
(12.3), 20–24 (55.7), and 25–29 (90.6) were again at rec-
ord lows in 2013, whereas the rates for men aged 35–39
(66.6), 40–44 (27.0), and 45–49 (8.8) were the lowest in
more than 40 years (16). Birth rates declined less than
1 % for both white and black men in 2013 from 2012, to
43.8 and 58.0 births per 1,000 men aged 15–54, respect-
ively. Information on the age of the father is often miss-
ing on birth certificates of children born to women
under age 25 and to unmarried women. In 2013, the age
of the father was not reported for 13 % of all births,
32 % of births to all women under age 20, and 29 % of all
nonmarital births. Birth rates declined for women in their
20s and increased for most age groups of women aged 30
and over. The total fertility rate declined 1 % [62].
The idea that robust fertility for a man will continue well
past a woman’s decline in fertility is untrue [59, 61, 62].
In addition to the increased rates of obesity and
medical illness found in reproductive-aged women,
intentionally delayed childbearing is a trend among pro-
fessional couples [63]. Thus, university students plan to
have children at ages when female fertility is decreased
without being sufficiently aware of the age-related de-
cline in fertility. This increases the risk of involuntary in-
fertility in this group, which is alarming in view of the
great importance they put on parenthood [63]. On the
other hand, there has been recent evidence of increased
rate of first trimester spontaneous abortion with older
paternal age. For paternal age ≥35 years, the risk of
spontaneous abortion between 6 and 20 weeks of gesta-
tion was 1.27. This elevated risk was seen even when
evaluating only those couples where the maternal age
was <30 years. When divided by trimester, the risk of
first trimester miscarriage was 1.56 and the risk was 0.87
for second trimester loss [64].
Sexual life and fertility
Decreased coital frequency with age is due in part to di-
minished sexual functioning; however, sexual dysfunc-
tion itself has no known influence on germ cells and its
impact on infertility can be overcome by measures of
assisted reproductive technology [59, 65].
Studies have consistently shown that increasing male
age is associated with an increased time to pregnancy
and decreased pregnancy rates. However, only a few
studies have examined these outcomes while adjusting
for female age. Ford et al. performed Avon Longitudinal
Study of Pregnancy and Childhood, a large population-
based study in the United Kingdom. Surveys from 8559pregnancies were used to determine the effect of age on
time to pregnancy. After adjusting for female age, con-
ception during a 12-month period was 30 % less likely
for men over age 40 years as compared with men youn-
ger than age 30 years [66]. In addition to female age,
coital frequency, and sexual functioning are variables
that affect the time to conception and pregnancy rates.
Decreased sexual activity can decrease the chances of
conception, and erectile dysfunction (ED) increases with
age [67].
Molecular biomarkers in semen parameters
Male factor infertility is a term that encompasses a host
of different conditions relating to sperm function that
may make it difficult for a sperm to fertilize an egg
under normal conditions [59].
Problems within male factor fertility may be due to
changes in semen quality as assessed by the semen
plasma analysis [59, 68–70]. Seminal plasma is a promis-
ing biological fluid to use for noninvasive clinical diag-
nostics of male reproductive system disorders to verify a
list of prospective male infertility biomarkers [68].
Molecular biomarkers hold promise to advance the
noninvasive diagnosis of male reproductive system disor-
ders and facilitate the identification and management of
these conditions through screening, early diagnosis, and
more accurate prognosis.
Seminal plasma proteins arise from secretions from sem-
inal vesicles (~65 % of semen volume), prostate (~25 %),
testis and epididymis (~10 %), and bulbourethral and periur-
ethral glands and has great potential as a proximal fluid for
protein biomarker discovery and as a clinical sample for
noninvasive diagnostics [60]. The most significant changes
are a low sperm concentration (oligospermia), poor sperm
motility (asthenospermia), and abnormal sperm morphology
(teratospermia) [51]. Collection of fluids secreted by individ-
ual glands provides samples enriched with tissue-specific
proteins. For example, expressed prostatic secretions can be
obtained in prostate massage, whereas epididymal and sem-
inal vesicle fluids are collected by microsurgical epididymal
sperm aspiration and seminal vesicle fluid by transrectal
ultrasonography-guided aspiration [69].
Evidence consistently indicates that sperm motility in
contrast to concentration decreases with advancing age.
Studies that adjusted for the duration of abstinence re-
vealed statistically significant decreases in motility by
0.17 to 0.6 % decrease per year of age [70].
Testis biopsy as a variant of a variety of surgical sperm
retrieval procedures can be performed for the purpose
of subsequent or simultaneous IVF/intracytoplasmic
sperm injection. The decision regarding the type of pro-
cedure should be based on the type of azoospermia, spe-
cific clinical circumstances, as well as on the surgeon’s
preference and experience [71].
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the human seminal plasma and identified 699 proteins.
By comparing the protein list with other previous prote-
omic data sets, they found that 2545 unique proteins
have been described so far in the human seminal plasma.
Authors profiled their expression at the gene level and
identified 83 testicular, 42 epididymis, 7 seminal vesicle,
and 17 prostate candidate protein markers. For a subset
of testis-specific candidates, i.e., TKTL1, LDHC, and
PGK2, their germ cell expression was validated and it
was demonstrated that such markers could be distin-
guished between semen from fertile and infertile men.
Several promising biomarkers for male infertility and
prostate cancer include ECM1, TEX101, LDHC, TKTL
and ACPP proteins [68, 69, 72, 73], and prostate specific
antigen (PSA), TMPRSS2-ETS [74].
The identification of genetic factors is important for
appropriate management of the infertile couple. In the
review by Ferlin et al. [75], 56 genes were mentioned as
responsible for male reproduction (ADAM2; ADAM20;
AKAP3; BAX; BCL2L10; BMP15; BRD2; C15ORF2;
C8ORF1; CNA1; CCT6B; CSNK2A2; CYLC1; D8S2298E;
DAZ; DAZL; DBY; FLJ13057; LJ20080; FOXJ1; FSHB;
FSHPRH1; HSF2BP; HYAL4; LOC56926; MAGOH;
MAK; MCSP; MOV10L1; NR6A1; ODF1; OR7C1;
OVOL1; PCMF; PIWIL1; PPAP2A; PRKAG1; PRM1;
PRM2; PROL1; RFP; SECP43; SMCY; SPAG1; SPAM1;
SPINLW1; STK22B; STK22C; STRBP; STRIN; SYCP1;
TCFL5; TESK2; TNP1; TXNDC2; ZP20) and 36 genes
for spermatogenesis (BCL2L10; BRD2; C15ORF2; CCNA1;
CCT6B; CSNK2A2; CYLC1; DAZ; DAZL; DBY; FOXJ1;
FSHPRH1; HSF2BP; MAK; MOV10L1; NR6A1; ODF1;
OR7C1; OVOL1; PIWIL1; PRKAG1; PRM1; PRM2; PROL1;
RFP; SECP43; SMCY; SPINLW1; STK22B; STK22C;
STRBP; SYCP1; TCFL5; TESK2; TNP1; TXNDC2). Several
human genes are known with mutations causing male infer-
tility (AR; AZF gene families; CFTR, DM-1, DNAH gene
family, FGFR1, FSHR, INSL3, KAL-1, LGR8-GREAT, LHR,
POLG) [76].
The specific seminal markers investigated were glu-
cosidase secreted by the epididymis, PSA and zinc se-
creted from the prostate, and fructose secreted by
seminal vesicles. Glucosidase, PSA, zinc, and fructose
levels are significantly lower in men aged over 50
years compared with men aged between 21 and 30
years [77].
Collection of the large list of identified biomarkers for
a rapid diagnostic tool for the short- and long-term
monitoring of pathological disorders and drug therapy is
a promising challenge for screening. For instance, the
collection of saliva, either any of biological fluids of hu-
man body, that is a fairly easy and noninvasive proced-
ure and not safe to the patients, has a strong potential
for predictive screening programs [78].The potential development of electronic tools for self-
monitoring via mobile gadgets would be a very attractive
solution of high-tech PPP medicine.Oxidative stress and nitrosative stress biomarkers for
male infertility screening and pregnancy planning
Nanoceria particle impact on oxidative stress which in-
cludes oxidative stress and nitrosative stress biomarkers
for male infertility screening and pregnancy planning is
essential. These are as follows:
 Oxidative stress biomarkers. DNA oxidation
biomarkers (oxidized DNA bases such as 8-OHdG,
autoantibodies to oxidized DNA, modified comet
assay), lipid oxidation (thiobarbituric acid-reactive
substances, exhaled pentane/ethane, low-density
lipoprotein resistance to oxidation, isoprostanes),
protein oxidation (protein carbonyls);
 Nitrosative stress biomarkers. NO, nitrite, peroxynitrite,
and inducible NO synthase (iNOS) expression,
modificated proteins, nitrosothiols, 8-nitroguanine
(a marker of nitrative DNA damage), etc. [79, 80].
As nanoceria were reported to impact on fertility [27]
and to have wide antioxidative properties in different tis-
sues [81], the profound study of the mechanism of its
action might be important to understanding some par-
ticular genesis of infertility.Apoptosis, infection
Sperm apoptosis is related to male age, body mass index
(BMI), testicular volume, and FSH. Among the apoptotic
markers, only DNA denaturation has been found to pre-
dict natural pregnancy better than conventional sperm
parameters [82, 83]. Thus, DNA denaturation correlated
positively with age and negatively with testicular volume
(TV). MMP correlated negatively with BMI and FSH
and positively with TV. Normal viable sperm correlated
positively with TV and negatively with age, BMI, and
FSH. DNA denaturation was associated with a signifi-
cantly lower natural pregnancy rate.
For men, viral orchitis and sexually transmitted infec-
tions can lead to infertility due to germinal cell damage,
ischemia, or the immune response to the infection.
Temporary inflammatory episodes in the male repro-
ductive tract which are self-limiting are probably com-
mon [84].
The risk of developing a medical condition or of being
exposed to environmental toxins increases with age, e.g.,
accumulation of the aging pigment lipofuscin increasing
with age, which decline Leydig cell and Sertoli cell num-
bers [59].
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Other factors less well associated with infertility include
semen volume and other seminal markers of epididymal,
prostatic, and seminal vesicle function. As men age,
these variables are impacted and correlate with de-
creased fertility [59].
Ultrasonography (ultrasound, US) is a widely used and
well-tolerated imaging modality for evaluation of patho-
logic conditions of the testes. Recent technical advances of
US applications and postprocessing developments have en-
abled new aspects in the structural and functional analysis
of testicular tissue and, therefore, male fertility [85–87].
Testicular ultrasound should be performed in every
patient with unexplained infertility and abnormal sperm
analysis. It allows diagnosis of more pathologic condi-
tions than physical examination (Fig. 7). The obtained
results demonstrating the increase of the rat testes vol-
ume on in vivo ultrasound exceeding morphological size
measurement were most likely due to blood perfusion in
tests in living animals’ tissues.
Several ultrasound scans of clinical observations of in-
fertile men are presented in Fig. 7 (examinations were
performed in Clinical Hospital “Pheophania” in Kyiv,Fig. 7 Ultrasound assessment of testes in infertile men—imaging biomarke
(T), tumor is better visualized using sonoelastography (performed on Hitach
as blue on the left side of the figure). c Testicle perfusion—Doppler. d Dopple
testicles (T) and effusion around both testiclesUkraine, using ultrasound equipment Hitachi HV900
and BK “Hawk”).
Besides a rapid varicocele screening, color Doppler
ultrasound allows us to evaluate its hemodynamic reper-
cussion by studying the spectral display, color, and re-
sponse to Valsalva’s. It also provides an exact measure of
testicular volume and allows to detect the presence of
dystrophic changes in the testicle, as well as anomalies
of the epididymis and vas deferens, such as cystic dila-
tions. It is also the test of choice to detect undescended
testicles. Ultrasound may also detect nonpalpable tes-
ticular tumors (Fig. 7b) which are more prevalent in this
group of patients [86].
Testicular size may be a surrogate marker of sperm-
atogenesis [88]. The size of the testis is almost un-
changed until the eighth decade, at which point the
testicular volume was reported to be 31 % lower than in
men aged 18 to 40 years [89]. The testes are responsible
for the production of spermatozoa and testosterone in
men. Approximately 80–90 % of the testicular volume is
made up of seminiferous tubules and germ cells [59].
Thus, a reduction in the number of these cells is mani-
fested in a reduction in testicular volume [88, 89].rs. a Testicular microlithiasis (arrow). b Testicular tumor—seminoma
i US equipment) that depicts stiff lesion in the parenchyma (colored
r spectrum of artery in testis. e Hydrocele—on US scan are visualized
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volume has a direct correlation to seminal fluid and sex
hormone assay, just like the simple measurement of tes-
ticular length, width, and depth [90].
The testicular volume can be calculated using (a) the
formula for an ellipsoid (formula 1): length (L) × width
(W) × height (H) × 0.52; (b) the formula for a prolate
spheroid (formula 2): L × W2 × 0.52; and (c) the empiric
formula of Lambert (formula 3): L × W × H × 0.71 [91].
Testicular microlithiasis (TM) can be revealed on
testicular ultrasounds (Fig. 7a) in men suffering from
the conditions such as scrotal pain, swelling, and infer-
tility [92].
In addition, evidence exists that testicular perfusion
assessed by routine color Doppler ultrasonography is
valuable for diagnosing scrotal abnormalities in infertile
men, frequently detecting nonpalpable lesions [93, 94].
Increased resistive index (RI) and pulsatility index (PI) of
capsular branches of testicular arteries on unenhanced
color Doppler US examination may be an indicator of
impaired testicular microcirculation.
Contrast-enhanced ultrasound (CEUS) imaging is po-
tentially applicable to the investigation of vascular disor-
ders of the testes providing additional information
regarding testes vascularity [86].
Evidence suggests that there is a mild decrease in sem-
inal volume with increasing age, although the clinical
significance of this finding is marginal. The decrease in
volume may be related to seminal vesicle insufficiency
because seminal vesicle fluid composes most of the
ejaculate volume [59].
Prostatic changes, including smooth muscle atrophy,
may also affect semen volume and sperm motility. Com-
plex use of radiological methods for prostate including
magnetic resonance imaging (MRI), magnetic resonance
(MR) spectroscopy, positron emission tomography
(PET), Doppler, sonoelastography, transrectal US-guided
prostate biopsy, and scrotal ultrasound provides signifi-
cant data to assess the health of men with infertility-
associated cases [92–96].
Transrectal ultrasonography-guided seminal vesicle
fluid aspiration biopsy is a safe and effective technique
to collect material for molecular/genetic biomarkers as-
sociated with spermatogenesis in infertile men [96].
Microdialysis needle might provide longitudinal in vivo
assessment of molecular tissue biomarkers, and the po-
tential to provide immediate feedback-guided treat-
ment and the relevant research in the field [97], e.g.,
tissue cadmium level, calcium channel sequence, and
other markers, may predict the outcome of varicocele
surgery [97].
Existing data suggest that there are wide geographical
variations in semen quality and in the incidence of tes-
ticular cancer, cryptorchidism, and hypospadias andemphasize the importance of the environmental antian-
drogenic compounds for the development of the testis
and reproductive tract. The data illustrate the similarities
between the effects of some environmental compounds
(as phthalate esters) and perceived decline in human
male reproductive health which comprises testicular dys-
genesis syndrome (TDS) [98]. Accumulation of toxic
agents including the products of cigarette smoke such as
cadmium was reported to be elevated in seminal plasma
from infertile men with varicocele (compared with those
without varicocele) [99].
Varicocele and hernia are the most common risk fac-
tors in men attending the infertility. In addition, strenu-
ous work could cause testicular injury [100]. Increased
apoptosis among developing germ cells was demon-
strated, which may be the cause of oligospermia and tes-
ticular tissue of men with varicoceles. The increased
levels of ROS were shown in association with poor
sperm motility; morphologically abnormal spermatozoa
have demonstrated disruption of actin in the sperm
heads by cadmium, and its cations were reported to be
present in high concentrations among some men with
varicoceles [99–101]. There was no evidence that anti-
sperm antibodies are responsible for the damage to
spermatogenesis in unilateral cases; however, measure-
ment of the serum hormones showed elevations of LH
and FSH which cannot be entirely explained as second-
ary to the damaged spermatogenesis. There was weak
but nevertheless significant evidence that testis maldes-
cent may be a poor prognostic factor as far as subse-
quent fertility [101, 102].
Patients demonstrating congestive phenomena with
predominance in the pelvis and increased temperature
in testes is a large group, who should be stratified in/
subfertility management. Interactions between skeletal
muscle spasticity, myofascial pain pelvic pain, and pelvic
floor muscle dysfunction [103] and also with microcircu-
lation disorders due to vasospasm like Flammer syn-
drome [104] might give intriguing pathogenesis clues in
understanding this psyche–intestine–circulation–pain–
movement–hormonal interaction as a whole.
Mohr et al. recently conducted the cohort controlled
study for confounding factors such as chronic illness,
BMI, medications, and lifestyle when analyzing testoster-
one levels. They reported that chronic disease and high
BMI significantly decreased testosterone concentrations,
whereas smoking tended to increase a total, free, and
bioavailable testosterone concentration. Finally, declin-
ing testosterone may cause a decline in libido, erectile
dysfunction, and difficulty achieving ejaculation [105].
Metabolic syndrome
Metabolic syndrome (MetS) is a compilation of symp-
toms including central obesity, insulin resistance,
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resistance, and hypertension and comprises an array of
cardiovascular disease (CVD) risk factors [106–109].
Currently, there is sufficient evidence to suggest a
MetS–male infertility paradigm. Obesity/overweight may
result in hypogonadism, increased scrotal temperatures,
impaired spermatogenesis, decreased sperm concentration
and motility, and increased sperm DNA damage. Simi-
larly, noninsulin-dependent diabetes mellitus (NIDDM)/
insulin resistance may contribute to and compound this
scenario. Dyslipidemia with increased oxidative stress in
the testicular microenvironment and/or an excurrent
ductal system may further decrease fertility [106, 107].
Currently, there are limited prospective studies exam-
ining the effects of treating metabolic syndrome on male
reproduction, and these relationships will need to be a
focus of further investigation [106, 107]; additional stud-
ies are needed to fully elucidate the pathophysiologic
link between the components of MetS and male
infertility.
Retrospective analysis of the clinical, laboratory
(spermatic, microbiological, and hormonal), ultrasonog-
raphy integrated data led on a diabetic population with
the vascular extra-genital pathology confirms data rela-
tive to the heterogeneity of the clinic-andrological pres-
entation of the diabetic patient [109, 110]. Diabetes is
associated with increased sperm nuclear and mtDNA
damage that may impair the reproductive capability of
men [111].
The links of neurodegenerative diseases (NDD) with
male infertility is not still supported by solid evidence.
However, a large proportion of infertile males are still
diagnosed as idiopathic, reflecting poor understanding of
the basic mechanisms regulating spermatogenesis and
sperm function [76].
Male in/subfertility and erectile dysfunction treatment
approaches
There are few commonly accepted treatments for male
subfertility [112–114]. Antioxidative agents are in focus
for search of new treatment modalities, as the excessive
generation of reactive oxygen species by abnormal
spermatozoa and leukocytospermia has been identified
as one of the few defined etiologies for male infertility.
Seminal oxidative stress in the male reproductive tract is
known to result in peroxidative damage of the sperm
plasma membrane and loss of its DNA integrity. Nor-
mally, a balance exists between concentrations of react-
ive oxygen species and antioxidant scavenging systems.
However, during genitourinary infection/inflammation,
these antioxidant mechanisms may downplay and create
a situation called oxidative stress. Limited endogenous
mechanisms exist to reverse these damages. In a normal
situation, the seminal plasma contains antioxidantmechanisms which are likely to quench these ROS and
protect against any likely damage to spermatozoa.
One of the rational strategies to counteract the oxida-
tive stress is to increase the scavenging capacity of sem-
inal plasma.
Numerous studies have evaluated the efficacy of anti-
oxidants in male infertility [22, 106, 113–115].
Therefore, antioxidants such as vitamin C, vitamin E,
glutathione, and coenzyme Q10 have proven beneficial
effects in treating male infertility. A multifaceted thera-
peutic approach to improve male fertility involves identi-
fying harmful environmental and occupational risk
factors while correcting underlying nutritional imbal-
ances to encourage optimal sperm production and func-
tion [113–115].
Conducted quantitative meta-analysis improves preci-
sion where individual trials are not powerful enough to
demonstrate moderate treatment effects. The quality of
most trials is poor. Although many clinical trials have
demonstrated the beneficial effects of antioxidants in se-
lected cases of male infertility, some studies failed to
demonstrate the same benefit. The majority of the stud-
ies suffer from a lack of placebo-controlled, double-blind
design, making it difficult to reach a definite conclusion.
In addition, investigators have used different antioxi-
dants in different combinations and dosages for varying
durations.
Pregnancy, the most relevant outcome parameter of
fertility, was reported only in a few studies, and few
conventional treatments (i.e., those not involving
assisted conception techniques) result in improved fer-
tility rates [112].
Most studies failed to examine the effect of antioxi-
dants on a specific group of infertile patients with high
oxidative stress. Multicenter, double-blind studies with
statistically accepted sample size are still needed to pro-
vide conclusive evidence on the benefit of antioxidants
as a treatment modality for patients with male infertility.
Thus, so far, the studies which assessed therapies of
infertile men with potential treatment agents found no
improvement in sperm parameters after treatment
[112–115].
Diet
Development of person-oriented diets is in the focus of
PPPM which have a beneficial impact on many aspects
of health [116, 117] and male fertility [118, 119]. Despite
the fact that precise mechanisms have yet to be estab-
lished, there is a significant role for both diet and phys-
ical activity to improve the many factors associated with
the metabolic syndrome, including modulation of vari-
ous adipocytokines [107–109].
Popular dietary supplements like monosodium glutam-
ate were reported to evoke a toxic effect on testicular
Kobyliak et al. The EPMA Journal  (2015) 6:12 Page 16 of 22structure in rats, decrease testicular weight, decrease
tubular diameter, reduce germinal epithelium height, de-
crease the spermatic count, and cause abnormalities of
sperm morphology [120]. The beneficial effects of diet
correction including probiotics on glutamate-induced
metabolic disorders were demonstrated [117].
Although soy-based food consumption has been fre-
quently associated with beneficial health effects, it was
reported to include increased levels of phytoestrogens
(plant estrogen) and, endocrine-disrupting chemicals
(EDCs), having potential adverse effects on the repro-
ductive and endocrine systems, and fertility. Soybean is
the most important dietary source of isoflavones, an im-
portant class of phytoestrogen. The intake of isoflavone
can impact semen quality parameters and induce infer-
tility among men [121]. The phytoestrogens genistein
and vinclozolin, present in soy products, may increase
risks of the incidence of hypospadias up to 41 % with
consumption of genistein and vinclozolin together [122].
Thus, the vegetarian diet style that includes soy-based
foods might be associated with a higher risk on the male
reproductive male system.
In a study of the likely risk factors, such as smoking
and drinking habits, smoking and the density and viabil-
ity of sperm were suggested to be significant predictors
of male infertility [123].
Sport, physical activity
However, there is a little evidence that exercise training
induces male infertility; no evidence exists regarding the
exact pathophysiological mechanism operational in the
exercise-induced changes in the reproductive hormones
[124]. The inclusion of exercise training as a component
of male factor infertility has been proposed secondary to
changes observed in the reproductive hormone and
semen profile of some endurance-trained male athletes.
Controversial data exist regarding the effects of phys-
ical activity on fertility, with the prevalence of trials
demonstrating worsening of seminal parameters. Thus, a
subset of endurance-trained men, particularly runners,
present with subclinical changes in their reproductive
hormone profile [125]. Some activity is unfavorable for
fertility as, e.g., mechanical trauma to the testes associ-
ated with cycling and/or increased gonadal temperature;
however, it has not been suggested that endurance exer-
cise adversely affect the hypothalamic–pituitary–testis
axis [126], strenuous work could cause testicular injury
[100]. It has been demonstrated that physical stress in
healthy male athletes can interfere with LH levels [127].
Bicycling was suggested to cause the prolonged com-
pression of perineal arteries leading to reduced chronic
penile perfusion inducing impotence [127], with an inci-
dence of erectile dysfunction 13–24 %. High frequency
of lower urinary tract symptoms (LUTS) in cyclists hasbeen related to increase the incidence of erectile dys-
function in comparison with a normal population.
A high incidence (up to 30 %) of varicocele has been
reported in a population of athletes and up to 60–80 %
in the subgroup of body builders. The incidence of vari-
cocele specifically increases with hours of training, in a
linear model [127].
According to a randomized controlled study by Safarinejad
et al. [128], long-term strenuous treadmill exercises
(overtraining syndrome) have a deleterious effect on
reproduction.
Unclear evidence exists on the effects of radiofre-
quency fields on human reproductive health [129–131].
Possible relationship was demonstrated between expos-
ure to radiofrequency fields during work with radar and
reduced fertility [130]. Radiofrequency electromagnetic
waves emitted from cell phones may lead to oxidative
stress in human semen [131]; thus, keeping the cell
phone in a trouser pocket in talk mode may negatively
affect spermatozoa and impair male fertility.Infertility-related PPPM-oriented questionnaires for men
health
Development, validation, and implementation of linguis-
tically validated evidence-supported PPPM-oriented
questionnaires for men health questionnaires are essen-
tial to assessment conditions specific to infertility which
is tailored to the person. A number of male health ques-
tionnaires are successfully used, such as Male Sexual
Health Questionnaire (MSHQ) [130], International Prostate
Symptom Score (IPSS) [132], Male Fertility Evaluation
Questionnaire by Dr. Schlegel [133], etc. International Index
of Erectile Function (IIEF) scores that are used for assess-
ment ED do not statistically differentiate among the specific
etiologies of ED as determined by evidence-based testing
with color duplex Doppler ultrasound testing [134]. On the
other hand, the IIEF-5 scores of men with psychological ED
were higher than those with organic causes, but there is no
difference among patients with different organic pathophysi-
ologies. Thus, IIEF-5 is not a definitive diagnostic tool to
discriminate the pathophysiological causes of ED [135].
For men health PPPM-oriented questionnaires, the
number of relevant data should be properly assessed and
gathered into one patient’s profile as follows: data of sex-
ual activity, libido, erectile function, difficulty achieving
ejaculation, testosterone levels, and information regarding
such factors as: BMI, chronic illness affecting hypothal-
amic–pituitary–testis axis, diabetes, CVD, neurodegenera-
tive diseases, asthma, etc. in relation to lifestyle, sport,
sauna, sport (bicycling), long-term strenuous work, mech-
anical trauma of testes, diet, alcohol consumption, smok-
ing, environmental intoxication (medications, cadmium,
etc.), exposure of radiofrequency fields, etc.
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might be included to the questionnaires, e.g., for telemedi-
cine consultations, if appropriately evaluated. Thus,
among anthropometric and genital measurements, ano-
genital distance was proved to provide a novel metric to
assess reproductive potential in men. A longer anogenital
distance is associated with fatherhood and may predict
normal male reproductive potential [136].
Construction of the intuitive visual analog scale
(VAS)-based questionnaires are much preferable as such
questionnaires have no significant differences with those,
text-based, like IPSS [137].
Couple health assessment within gender-related studies
for family-oriented health programs
Considering biosafety of ceria nanoparticles, the group
of potential patients (consumers) can be large and could
be suggested to infertile persons of both genders [1].
Women health has been widely assessed within the large
scope of factors affecting fertility, general health, with
pathways among lifestyle, diet, obesity, and gender-related
pathology [138, 139]. In men health, we still observe a lack
of such focused attention in research and health care.
Couple health assessment for smart planning social life
and reproduction is a new challenge. Support of prevent-
ive educational activity with a long-term commitment of
private and public funding programs is required.
Endpoints
According to cumulated data and conclusions of several
reviews (by Harris et al. [59], Drabovich et al. [69],
Purvis et al. [84], etc.), we can assume as follows:
1. The male reproductive tract is exquisitely vulnerable
to the effects of antiandrogens during development
due to the reliance on the synthesis and action of
androgens for the masculinization of the male
reproductive tract [98].
2. An aging has a significant impact on male sexual
function, sperm parameters, and fertility, which all
contribute to decreased fecundability, increased time
to conception, and increased miscarriage rates.
3. The trend for parenthood at an older age has also
been seen in men [61, 62].
4. Older men tend to have older female partners, and
increasing male age is associated with increased time
to conception. This reflects the age-related increase
in acquired medical conditions, decreases in semen
quality, and increasing rates of DNA fragmentation
seen in sperm.
5. The increased rate of DNA fragmentation leads to
an increase in fetal abnormalities [59].
6. The level of testosterone does appear to influence
sexual function. Declining testosterone may causethe decline in libido, erectile dysfunction, and
difficulty achieving ejaculation.
7. Viral orchitis and sexually transmitted infections can
lead to infertility due to germinal cell damage,
ischemia, or the immune response to the infection.
Infection impact
8. The following are the conclusions regarding the role
of infection in the etiology of male infertility from
review by Purvis et al. [84]: Temporary inflammatory episodes in the male
reproductive tract are probably common.
 A large number of men with poor sperm quality
have been detected to have a nonsymptomatic,
chronic prostatovesiculitis.
 Leukospermia or bacteriospermia are parameters for
glandular infection.
 Increasing evidence implicates Chlamydia
trachomatis as being a major cause of chronic
nonbacterial prostatitis; an important aspect of
chlamydial infections in men may be that the male
accessory sex glands may function as reservoirs for
the organism, increasing the probability of infection
in the female.
 Ureaplasma urealyticum may also play an important
etiological role in male infertility, but its significance
is confounded by its acknowledged function as a
commensal in the reproductive tract.
 One of the manifestations of male reproductive tract
infection is the induction of sperm autoantibodies.
 There is a need for more systematic controlled
studies of the effects of antibiotic treatment on
sperm quality.9. In/subfertility depend on many factors—internal and
environmental. Moreover, environmental factors,
such as pesticides, exogenous estrogens, and heavy
metals may negatively impact spermatogenesis since
male sperm counts were declined.
10.Cadmium intoxication is important in the etiology
of varicocele-associated infertility.
11.Oxidative stress is most important in genesis in/
subfertility; in addition, aging is also likely to further
induce oxidative stress.
12.Metabolic syndrome, DM, and CVD have a
significant impact on infertility.
13.Sports, hard work, smoking, soy-based food
consumption, and radiofrequency fields could
impact on a human reproductive health.
14.Multiparameter diagnostic assessment is essential
(using broad panel with imaging molecular and
clinical biomarkers).
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15.Key points for semen parameters were formulated
by Drabovich et al. in their review in Nature Reviews
Urology [69], as follows: “Seminal plasma contains a large number of tissue-
specific proteins secreted by individual organs of the
male reproductive system.
 Male reproductive system disorders result in altered
composition of the seminal plasma proteome.
 High concentrations of organ-specific proteins en-
able their accurate quantification by mass spectrom-
etry, facilitating biomarker discovery.
 As well as being a promising biological fluid for
biomarker discovery, seminal plasma might find a
unique niche as a clinical diagnostic fluid.
 Because cancer-specific proteins can appear earlier
in seminal plasma than in blood serum, seminal
plasma could facilitate the early diagnosis of prostate
and testicular cancers” [60].
 Microdialysis might be useful to provide relevant
tissue biomarkers in vivo.
Imaging data
 Ultrasound is a source of potential biomarkers,
including:
 Scrotal ultrasound can provide relevant markers like
testicle volume, blood flow (decline of perfusion,
increased RI); testicular microlithiasis, tumors;
seminal vesicles volume.
 Rectal ultrasound is useful for detecting prostate
hyperplasia; prostatitis (calcifications fibrosis and
cysts, compressing ejaculatory ducts), a
nonsymptomatic chronic prostatovesiculitis, deep
pelvic infections in the male; pelvic muscles
dysfunction; and bladder hypermobility, etc.
 Transrectal ultrasonography-guided biopsy of
reproduction organs and seminal vesicle fluid
aspiration are important instruments to gather
laboratory biomarkers.
Therapy approach
1. However, no effective evidence level 1 supported
treatment has still not been seen on the horizon.
2. Low toxic and environmental safe nanodrugs with
systemic multiorganic antioxidative properties are
important to be implemented to the clinical
practice.
3. Nanoceria being potential drugs that induce fertility
have beneficial properties affecting collateral fertility
modifying conditions due to their antioxidative,prokinetic, anti-inflammatory, antiviral, antibacterial,
antifungal, and UV-protectant activity.
4. Properly randomized controlled trials are necessary
to evaluate different subfertility treatments because
pregnancies and spontaneous improvements in
semen parameters occur without treatment that can
find out whether pregnancy rates are higher or
lower than expected after treatment [117].
Study limitations
The main limitation of the study was small number of
animals, however sufficient to obtain significant differ-
ences in most relevant parameter.
We have not assessed in the current research preg-
nancy rates, and the health of offspring as the most rele-
vant outcome parameter of fertility, and have not
included to the study the genetic factors, behavior, and
sexual activity. Many bias and confounding factors have
not been studied such as many health parameters in-
cluding infections, BMI, etc. However, many factors
missed in the methods were discussed through the
paper. These issues should be further studied using
properly developed infertility animal models designed in
particular for young infertile rats related to collateral
diseases affecting fertility with longitudinal assessment
of molecular markers (using microdialysis) and imaging
(using ultrasound, MRI, luciferase imaging) and also to
test efficacy of nanoceria to enhance female reproduction.
Drug delivery issues (theranostic, sonoporation) for infer-
tility are the next essential points for a further research.
The issue of potential environmental contamination by
nanoparticles due to their high penetration properties
should be properly studied before extensive use of the
nanoproducts.
Consolidation of the PPPM Men Health concept
The results of the study are potentially applicable to cre-
ate products, drugs and food supplements for treatment,
to develop safe and effective treatments for age-related
infertility beneficial for individual outcomes with par-
ticular application in elderly, to be a part of large con-
cept within interactome in order to suggest sustainable
healthy well-being and aging of men, and also to con-
tribute in understanding many aspects related to male
infertility and sexual life.
Preventive medical approach
Translation of the obtained data proceeding the animal
model to a human organism may allow to consider to
develop nanoceria-based additives/drugs against infertil-
ity in the particular application in elderly for treatment
and preventive activity. The results have a potential for
the prevention of spontaneous abortion with older
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grated vision of interactome.
Screening, diagnosis, therapy, and prevention of male
genital pathologies, such as varicocele, cryptorchidism, her-
nia, maldescent testes, testicular and prostate tumors, geni-
tourinary infections, etc., study infertility and erectile
dysfunction in the population involved in sports activities
[121], identify adverse environmental and occupational risk
factors, and correct underlying nutritional imbalances.
Another important fields recently discovered for
PPPM approaches are essential to be applied in the matter,
such as ecology medicine, development healthy individu-
alized sports programs, diets, and support health-oriented
fashion, dresses, furniture, transport design, and develop-
ment sophisticated electronic gadgets [140].
Predictive medical approach
Smart reproduction planning and the planning of own
person’s social life is the earliest and most important
time point for effective predictive medicine for a future
generation of a healthy society.
Men health in the point of view of reproduction and
personal health and life quality is still not sufficiently
studied and implemented to predictive assessment and
widespread screening programs. Developing the panel of
biomarkers for assessment age-related fertility for exten-
sive vision of Men Health from the comprehensive view
of including hypothalamic–pituitary–testis axis [141],
psyche, stress, emotions, pain, physical activity, gut–
brain axis (GBA), and molecular and cellular mecha-
nisms is an important point. Development and validation
of comprehensive and concise questionnaires for diagno-
sis male aging organism and sexual and reproductive life
as a part of men health panel of biomarkers is strongly
recommended.
Personalized medical approach
Designing person-related smart physiologic low-dose
treatments is a challenge for medicine of the future. The
clinical study is necessary for stratifications of potential
responders to formulate clear personalized application.
Considering biosafety of ceria nanoparticles, the group
of potential patients (consumers) can be large and may
be suggested to infertile persons of both genders.
Recent advances suggested that in order to create
ex vivo systems for the generation of artificial sperm
starting from immature germ cells from infertile pa-
tients, the personalized in vitro applications of nanoceria
to enhance sperm quality and development of artificial
sperm are allowed to be considered [142].
To suggest solutions to interact with industry to pro-
duce person-specific-shaped personalized fashion,
dresses, furniture, transport design [140], and also via
personalized manufacturing using 3D printing.Conclusions
In conclusion, the present work confirmed that adminis-
tration for 10 days of citrate coated 2–5-nm CNPs lead
to increase sex hormone levels, sperm count, and qual-
ity, as well as the activation of spermatogenesis in 24-
month-old male rats. These changes were related to the
improvement of serum oxidative–antioxidative balance.
Expert recommendations
With the concluding points, we can formulate the fol-
lowing proposals (expert recommendations):
 To prepare an international research project to
study the biomedical effects of nanoceria, capable to
reduce the level of oxidative stress in diverse tissues
of human body and potential as a drug inducing
fertility with prokinetic, anti-inflammatory, antiviral,
antibacterial, antifungal, and UV protectant activity.
 To initiate discussion to suggest the project with an
extensive vision of Men Health within the
comprehensive concept within PPPM for sustainable
well-being and aging of men.
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